Cancer HealthCast: New Technologies Lead to Major Breakthroughs in Cancer Detection, Screening at NCI
Two key programs are playing a vital role in detecting and diagnosing cancer as well as reducing the overall burden on patients and their families.
The National Cancer Institute is utilizing a host of new technologies to diagnose and detect cancer thanks to its Innovative Molecular Analysis Technologies (IMAT) and Informatics Technology for Cancer Research (ITCR) programs. These programs are developing methods that are enhancing cancer research, including artificial intelligence.
Dr. Kelly Crotty, program director for NCI’s Center for Strategic Scientific Initiatives, said not only have the programs helped researchers better identify and screen for cancer, but also they’ve been instrumental in driving progress in clinical care. Crotty also shares updates about NCI’s Liquid Biopsy Consortium and discusses the benefits and challenges she’s seeing with AI.
-
Dr. Kelly Crotty Program Director, Center for Strategic Scientific Initiatives NCI
-
Federal Agencies Navigate Tradeoffs Between AI Speed, Security
Agencies are deploying AI to drive mission outcomes, while managing challenges around security, data protection and oversight.
3m read -
VA Uses Automation, AI to Process Record Benefits Claims
VA officials say automated tools improved claims accuracy while reducing processing times and backlogs across benefits programs.
4m read -
Modernizing Federal Contact Centers
Officials discuss how CX-driven strategies are modernizing contact centers and strengthening security and service delivery.
30m watch Partner Content -
AI Decision Support System Aims to Improve Battlefield Triage
APPRAISE helps combat medics identify hemorrhage risk earlier and make faster triage and evacuation decisions.
7m watch
